Dual Targeting Biomimetic Liposomes for Paclitaxel/DNA Combination Cancer Treatment
AbstractCombinations of chemotherapeutic drugs with nucleic acid has shown great promise in cancer therapy. In the present study, paclitaxel (PTX) and DNA were co-loaded in the hyaluronic acid (HA) and folate (FA)-modified liposomes (HA/FA/PPD), to obtain the dual targeting biomimetic nanovector. The prepared HA/FA/PPD exhibited nanosized structure and narrow size distributions (247.4 ± 4.2 nm) with appropriate negative charge of −25.40 ± 2.7 mV. HA/FA/PD (PTX free HA/FA/PPD) showed almost no toxicity on murine malignant melanoma cell line (B16) and human hepatocellular carcinoma cell line (HepG2) (higher than 80% cell viability), demonstrating the safety of the blank nanovector. In comparison with the FA-modified PTX/DNA co-loaded liposomes (FA/PPD), HA/FA/PPD showed significant superiority in protecting the nanoparticles from aggregation in the presence of plasma and degradation by DNase I. Moreover, HA/FA/PPD could also significantly improve the transfection efficiency and cellular internalization rates on B16 cells comparing to that of FA/PPD (p < 0.05) and PPD (p < 0.01), demonstrating the great advantages of dual targeting properties. Furthermore, fluorescence microscope and flow cytometry results showed that PTX and DNA could be effectively co-delivered into the same tumor cell via HA/FA/PPD, contributing to PTX/DNA combination cancer treatment. In conclusion, the obtained HA/FA/PPD in the study could effectively target tumor cells, enhance transfection efficiency and subsequently achieve the co-delivery of PTX and DNA, displaying great potential for optimal combination therapy. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Liu, G.-X.; Fang, G.-Q.; Xu, W. Dual Targeting Biomimetic Liposomes for Paclitaxel/DNA Combination Cancer Treatment. Int. J. Mol. Sci. 2014, 15, 15287-15303.
Liu G-X, Fang G-Q, Xu W. Dual Targeting Biomimetic Liposomes for Paclitaxel/DNA Combination Cancer Treatment. International Journal of Molecular Sciences. 2014; 15(9):15287-15303.Chicago/Turabian Style
Liu, Guo-Xia; Fang, Gui-Qing; Xu, Wei. 2014. "Dual Targeting Biomimetic Liposomes for Paclitaxel/DNA Combination Cancer Treatment." Int. J. Mol. Sci. 15, no. 9: 15287-15303.